Gain-of-function mutations of CD79B often co-occur with MYD88 mutations, with significantly higher frequency in ABC DLBCLs, while CD79A mutations are uncommon, ranging from 2.9% to 4% of cases [8,12]. This evidence concerns the gene CD79B and aneurysmal bone cyst.